Premier Alternatives

C the Signs

London, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of a cancer detection platform intended to detect cancer at the curable stage. C the Signs is based in London, United Kingdom and was founded in 2017. Its last reported valuation was $31.8 million in Feb 2022. It has raised $21 million.

Last reported valuation
$31.8M
Oct 2026
Priced at
—
Total raised
$21.0M
Last round
—
No prints on record

No secondary trades in C the Signs shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of C the Signs with a free account
  • ·The complete investor list: 15 names
  • ·Watch C the Signs: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where C the Signs prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of C the Signs stock.